Novartis and Gates Foundation Team Up To Deliver Affordable Sickle Cell Gene Therapy

Novartis and the Bill & Melinda Gates Foundation have partnered on a single-dose, in vivo gene therapy for sickle cell disease (SCD). The foundation has offered to fund the development of the therapy.  Read the full article HERE